aspirin has been researched along with Proliferative Vitreoretinopathy in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety and efficacy of a new surgical method of intravitreal tamponade using silicone oil suspended with aspirin (acetylsalicylic acid) was investigated for the treatment of proliferative vitreoretinopathy." | 5.14 | Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study. ( Binder, S; Egger, S; Haas, A; Kieselbach, GF; Kralinger, MT; Parel, JM; Stolba, U; Velikay, M; Wedrich, A, 2010) |
| "Proliferative vitreoretinopathy is a severe reactive process which leads to the formation of cellular membranes on the surface of the retina and in the vitreous." | 1.29 | Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid. ( Göttinger, W; Kähler, CM; Kieselbach, GF; Reinisch, N; Troger, J; Wiedermann, CJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kralinger, MT | 1 |
| Stolba, U | 1 |
| Velikay, M | 1 |
| Egger, S | 1 |
| Binder, S | 1 |
| Wedrich, A | 1 |
| Haas, A | 1 |
| Parel, JM | 1 |
| Kieselbach, GF | 2 |
| Kähler, CM | 1 |
| Reinisch, N | 1 |
| Troger, J | 1 |
| Göttinger, W | 1 |
| Wiedermann, CJ | 1 |
| Elaxel, CJ | 1 |
| Blach, RK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Challenge Test for Acetylsalicylic Acid Hypersensitivity[NCT01681615] | 50 participants (Anticipated) | Interventional | 2012-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for aspirin and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Austria; Double-Blind Method; Drainage; Drug Combinations; | 2010 |
2 other studies available for aspirin and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid.
Topics: Adult; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Cataract; Cell Division; Cells, Cultured; | 1994 |
Aspirin is a hazard for vitreoretinal surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Emergencies; Humans; Intr | 1996 |